Océanie · Actualité · The Mercury

Optiscan’s digital pathology tech hits major US FDA milestone

Publié par The Mercury · Australie il y a 15 h

Optiscan Imaging has hit a major US regulatory milestone, lodging its FDA 510(k) submission for InForm and moving the digital pathology device into formal review.

Lire l'article complet sur The Mercury Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.themercury.com.au)

Optiscan’s digital pathology tech hits major US FDA milestone

À lire aussi

Revealed: Hawks’ opening offer for Merrett as trade war resumes

Revealed: Hawks’ opening offer for Merrett as trade war resumes

Revealed: Hawks’ opening offer for Merrett as trade war resumes

‘Left with no choice’: Jetstar workers to strike at major airports ahead of Grand Final weekend

View from The Hill: how far will the opposition go on industrial relations reform? Probably not too far

First home buyers with big loans among those most at risk of falling into negative equity, RBA warns

Optiscan’s digital pathology tech hits major US FDA milestone

Partager

À lire aussi

Revealed: Hawks’ opening offer for Merrett as trade war resumes

Revealed: Hawks’ opening offer for Merrett as trade war resumes

Revealed: Hawks’ opening offer for Merrett as trade war resumes

‘Left with no choice’: Jetstar workers to strike at major airports ahead of Grand Final weekend

View from The Hill: how far will the opposition go on industrial relations reform? Probably not too far

First home buyers with big loans among those most at risk of falling into negative equity, RBA warns